These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Successful treatment of a patient with severe Churg-Strauss syndrome by a combination of pulse corticosteroids, pulse cyclophosphamide, and high-dose intravenous immunoglobulin. Takigawa N; Kawata N; Shibayama T; Tada A; Kimura G; Munemasa M; Soda R; Takahashi K J Asthma; 2005 Oct; 42(8):639-41. PubMed ID: 16266953 [TBL] [Abstract][Full Text] [Related]
17. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. Kim S; Marigowda G; Oren E; Israel E; Wechsler ME J Allergy Clin Immunol; 2010 Jun; 125(6):1336-43. PubMed ID: 20513524 [TBL] [Abstract][Full Text] [Related]
18. Recent progress in the pharmacotherapy of Churg-Strauss syndrome. Hellmich B; Gross WL Expert Opin Pharmacother; 2004 Jan; 5(1):25-35. PubMed ID: 14680433 [TBL] [Abstract][Full Text] [Related]
19. Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy. Taniguchi M; Tsurikisawa N; Higashi N; Saito H; Mita H; Mori A; Sakakibara H; Akiyama K Allergol Int; 2007 Jun; 56(2):97-103. PubMed ID: 17460439 [TBL] [Abstract][Full Text] [Related]
20. Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal? Wechsler ME; Pauwels R; Drazen JM Drug Saf; 1999 Oct; 21(4):241-51. PubMed ID: 10514017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]